Showing results (1941-1950 of 2,051) with videos related to

Sort By:
Pageof 206
Plos One|May 12, 2021
Adolescent well-being and learning in times of COVID-19-A multi-country study of basic psychological need satisfaction, learning behavior, and the mediating roles of positive emotion and intrinsic motivationJulia Holzer, Selma Korlat, Christian Haider, et al.
Transplantation Direct|February 12, 2025
Neoadjuvant Multiagent Systemic Therapy Approach to Liver Transplantation for Perihilar CholangiocarcinomaNadine Soliman, Ashton A Connor, Ashish Saharia, et al.
Mucosal Immunology|June 17, 2018
BVES is required for maintenance of colonic epithelial integrity in experimental colitis by modifying intestinal permeabilityYash A Choksi, Vishruth K Reddy, Kshipra Singh, et al.
Cancer Immunology, Immunotherapy : CII|March 17, 2022
Epstein-Barr virus-induced ectopic CD137 expression helps nasopharyngeal carcinoma to escape immune surveillance and enables targeting by chimeric antigen receptorsMukul Prasad, Sashigala Ponnalagu, Qun Zeng, et al.
Gut|April 9, 2017
BVES regulates c-Myc stability via PP2A and suppresses colitis-induced tumourigenesisBobak Parang, Andrew M Kaz, Caitlyn W Barrett, et al.
Stroke|February 6, 2016
Predicting Intracerebral Hemorrhage Growth With the Spot Sign: The Effect of Onset-to-Scan TimeDar Dowlatshahi, H Bart Brouwers, Andrew M Demchuk, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|December 2, 2021
Survival following liver transplantation for locally advanced, unresectable intrahepatic cholangiocarcinomaRobert R McMillan, Milind Javle, Sudha Kodali, et al.
Haematologica|August 3, 2019
Leprosy drug clofazimine activates peroxisome proliferator-activated receptor-γ and synergizes with imatinib to inhibit chronic myeloid leukemia cellsHarish Kumar, Sourav Chattopadhyay, Nabanita Das, et al.
Iscience|April 20, 2026
Hypoxia-induced metabolic and apoptotic reprogramming enhances immunomodulation in Wharton's jelly mesenchymal stem cellsMohini Mendiratta, Meenakshi Mendiratta, Sujata Mohanty, et al.
The Lancet. Gastroenterology & Hepatology|July 30, 2018
Risankizumab in patients with moderate to severe Crohn's disease: an open-label extension studyBrian G Feagan, Julián Panés, Marc Ferrante, et al.
Pageof 206